Articoli con mandati relativi all'accesso pubblico - Daniel D. BuchananUlteriori informazioni
Non disponibili pubblicamente: 8
Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study
DD Buchanan, M Clendenning, L Zhuoer, JR Stewart, S Joseland, ...
Gut 66 (6), 1170-1172, 2017
Mandati: National Health and Medical Research Council, Australia
Improving identification of lynch syndrome patients: A comparison of research data with clinical records
YY Tan, J McGaughran, K Ferguson, MD Walsh, DD Buchanan, JP Young, ...
International journal of cancer 132 (12), 2876-2883, 2013
Mandati: National Health and Medical Research Council, Australia
Phenotypic confirmation of oligodontia, colorectal polyposis and cancer in a family carrying an exon 7 nonsense variant in the AXIN2 gene
C Beard, R Purvis, IM Winship, FA Macrae, DD Buchanan
Familial Cancer 18, 311-315, 2019
Mandati: National Health and Medical Research Council, Australia
A genomic test for colorectal cancer risk: is this acceptable and feasible in primary care?
S Saya, JG McIntosh, IM Winship, M Clendenning, S Milton, J Oberoi, ...
Public Health Genomics 23 (3-4), 110-121, 2020
Mandati: National Health and Medical Research Council, Australia, Cancer Research UK
Rare germline variants in the AXIN2 gene in families with colonic polyposis and colorectal cancer
JM Chan, M Clendenning, S Joseland, P Georgeson, K Mahmood, ...
Familial Cancer, 1-15, 2022
Mandati: National Health and Medical Research Council, Australia
Informed choice and attitudes regarding a genomic test to predict risk of colorectal cancer in general practice
S Saya, JG McIntosh, IM Winship, S Milton, M Clendenning, M Kyriakides, ...
Patient Education and Counseling 105 (4), 987-995, 2022
Mandati: National Health and Medical Research Council, Australia, Cancer Research UK
Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study
JE Joo, H Jayasekara, EM Wong, M Clendenning, C Rosty, IM Winship, ...
Gut 68 (4), 761-762, 2019
Mandati: National Health and Medical Research Council, Australia
Waist circumference, a body shape index, and molecular subtypes of colorectal cancer: A pooled analysis of four cohort studies
CV Chalitsios, G Markozannes, C Papagiannopoulos, EK Aglago, ...
Cancer Epidemiology, Biomarkers & Prevention, 2025
Mandati: National Health and Medical Research Council, Australia, Cancer Research UK
Disponibili pubblicamente: 268
Identification of Lynch syndrome among patients with colorectal cancer
L Moreira, F Balaguer, N Lindor, A De la Chapelle, H Hampel, ...
Jama 308 (15), 1555-1565, 2012
Mandati: US National Institutes of Health, Government of Spain
Prevalence and penetrance of major genes and polygenes for colorectal cancer
AK Win, MA Jenkins, JG Dowty, AC Antoniou, A Lee, GG Giles, ...
Cancer Epidemiology, Biomarkers & Prevention 26 (3), 404-412, 2017
Mandati: US National Institutes of Health, National Health and Medical Research …
Discovery of common and rare genetic risk variants for colorectal cancer
JR Huyghe, SA Bien, TA Harrison, HM Kang, S Chen, SL Schmit, ...
Nature genetics 51 (1), 76-87, 2019
Mandati: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Association between molecular subtypes of colorectal cancer and patient survival
AI Phipps, PJ Limburg, JA Baron, AN Burnett-Hartman, DJ Weisenberger, ...
Gastroenterology 148 (1), 77-87. e2, 2015
Mandati: US National Institutes of Health
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
L Baglietto, NM Lindor, JG Dowty, DM White, A Wagner, ...
Journal of the national cancer institute 102 (3), 193-201, 2010
Mandati: US National Institutes of Health, Cancer Research UK, Chief Scientist Office …
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer
D Mouradov, C Sloggett, RN Jorissen, CG Love, S Li, AW Burgess, ...
Cancer research 74 (12), 3238-3247, 2014
Mandati: Australian Research Council, National Health and Medical Research Council …
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
N Papadimitriou, N Dimou, KK Tsilidis, B Banbury, RM Martin, SJ Lewis, ...
Nature communications 11 (1), 597, 2020
Mandati: US National Institutes of Health, Cancer Research UK, National Institute for …
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study
AK Win, JP Young, NM Lindor, KM Tucker, DJ Ahnen, GP Young, ...
Journal of clinical oncology 30 (9), 958-964, 2012
Mandati: US National Institutes of Health
Cancer Risks for MLH1 and MSH2 Mutation Carriers
JG Dowty, AK Win, DD Buchanan, NM Lindor, FA Macrae, M Clendenning, ...
Human mutation 34 (3), 490-497, 2013
Mandati: US National Institutes of Health, National Health and Medical Research …
Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors
J Jeon, M Du, RE Schoen, M Hoffmeister, PA Newcomb, SI Berndt, ...
Gastroenterology 154 (8), 2152-2164. e19, 2018
Mandati: US National Institutes of Health, National Health and Medical Research …
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
AI Phipps, DD Buchanan, KW Makar, AK Win, JA Baron, NM Lindor, ...
British journal of cancer 108 (8), 1757-1764, 2013
Mandati: US National Institutes of Health
Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening
JN Poynter, KD Siegmund, DJ Weisenberger, TI Long, SN Thibodeau, ...
Cancer Epidemiology Biomarkers & Prevention 17 (11), 3208-3215, 2008
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software